- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Gland Pharma Limited — Updates, 28-01-2026: Press Release
28-01-2026 | 05:23 pm
28-01-2026 | 05:23 pm
Gland Pharma reports strong Q3 FY26 results: Revenue up 22% YoY to ₹1,695.4 Cr, adj. PAT up 37% to ₹279.7 Cr. Growth was driven by robust US & Europe sales and Cenexi reaching breakeven. New launches and a significant oncology CMO contract signal future potential.
No comments yet. Be the first to comment!